| Socioeconomic Costs of Age-related Macular Degeneration in Korea. |
|
Yongsun Ahn, Donghyun Jee |
1Department of Ophthalmology, College of Medicine, The Catholic University of Korea, Seoul, Korea. donghyunjee@catholic.ac.kr
2Suncheon Public Health Center, Suncheon, Korea. |
| 한국인 연령관련황반변성환자의 사회적 비용 분석 |
|
안용선1,2 · 지동현1 |
|
가톨릭대학교 의과대학 안과학교실1, 순천시 보건소2 |
Correspondence:
Donghyun Jee,
Email: donghyunjee@catholic.ac.kr
|
|
Received: 21 June 2018 • Revised: 19 September 2018 • Accepted: 18 July 2019 |
| Abstract |
PURPOSE
To estimate the annual socioeconomic costs of age-related macular degeneration (AMD) in the Republic of Korea. METHODS: We estimated the costs of illness to society of AMD patients, including medical, nonmedical, and productivity costs. The medical costs included official and nonofficial medical costs, and the nonmedical costs consisted of transportation, time, and nursing costs. We used Korea National Health Insurance Claims Database, National Health Insurance Service-National Sample Cohort, and Korea Health Panel study data in the analysis. RESULTS: The socioeconomic costs of AMD were estimated to be 694 billion Korean won (KRW) in 2016. This figure was divided into 501 billion KRW (72.1%) for medical costs, 61 billion KRW (8.8%) for nonmedical costs, and 133 billion KRW (19.1%) for productivity costs. The annual per capita socioeconomic cost of AMD was 1.32 million KRW. CONCLUSIONS: We determined the scale and composition of the socioeconomic costs of AMD. Importantly, the productivity costs accounted for approximately 20% of all costs, suggesting that AMD had a significant impact on productivity. Because the disease costs of AMD are expected to increase continuously with the aging population, effective planning at the governmental level for prevention and treatment of AMD should be considered to reduce socioeconomic costs. |
| Key Words:
Age-related macular degeneration;Costs;Disease costs;Socioeconomic costs |
|
PDF Links
Full text via DOI
Download Citation
